一个多中心,单臂研究,使用修改后的法里西马布治疗和延长疗法治疗因中枢视网膜静脉封闭而导致黄斑胀的患者:RVOSTAR研究设计协议
Mineo Kondo1, Masahiko Shimura2, Akitaka Tsujikawa3
1Department of Ophthalmology, Mie University Graduate School of Medicine, Mie, Japan.
PloS one
|October 30, 2025
概括
在日本,RVOSTAR研究评估法里西马布治疗视网膜静脉封闭性黄斑. 这种双 angiopoietin-2 / VEGF 抑制剂使用修改后的治疗和延长方案来长期维持视力.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗血管内皮生长因子 (抗VEGF) 药物是视网膜静脉闭塞与黄斑 (RVO-ME) 的标准.
- 日本目前的抗VEGF疗法在中部RVO-ME (CRVO-ME) 的长期视力维护方面扎.
- 法里西马布是一种双抗血管素-2/VEGF抑制剂,已被批准用于日本的RVO-ME.
研究的目的:
- 为了评估日本CRVO-ME或hemi-RVO-ME (HRVO-ME) 患者的法里西马布的长期视力结果.
- 评估法里西马布修改后的治疗和延长 (T&E) 疗程对以前未接受治疗的患者的疗效.
- 确定影响视觉敏度和最佳治疗间隔的因素.
主要方法:
- RVOSTAR研究是一项前性,干预性,单臂多中心试验,在日本进行.
- 患者最初每4周服用6毫克法里西马布,直到黄斑胀消失,然后观察和T&E疗程长达72周.
- 主要终点:最佳校正视敏度 (BCVA) 与基线在第72周的变化. 安全结果包括不良事件.
主要成果:
- 该研究旨在证明视力结果的长期维持.
- 它将评估法里西马布在改善和维持视力敏度方面的有效性.
- 该研究将提供关于法里西马布在该患者群体中的安全性概况的数据.
结论:
- 该RVOSTAR研究将评估CRVO-ME/HRVO-ME患者的法里西马布T&E的长期视力维护.
- 这种方法可以减少频繁注射的负担.
- 这些发现可以在临床实践中优化法里西马布的剂量频率.
相关概念视频
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


